40066 Federal Register / Vol. 86, No. 140 / Monday, July 26, 2021 / Notices 

improvements to such activities and 

research. 

DATES: The meeting will be held online 

via webcast on August 26, 2021 from 

approximately 9:00 a.m. to 5:00 p.m. ET 

(times are tentative and subject to 

change). The confirmed times and 

agenda items for the meeting will be 

posted on the TBDWG web page at 

https://www.hhs.gov/ash/advisorycommittees/tickbornedisease/meetings/ 

2021-08-26/index.html when this 

information becomes available. 

FOR FURTHER INFORMATION CONTACT: 

James Berger, Designated Federal Officer 

for the TBDWG; Office of Infectious 

Disease and HIV/AIDS Policy, Office of 

the Assistant Secretary for Health, 

Department of Health and Human 

Services, Mary E. Switzer Building, 330 

C Street SW, Suite L600, Washington, 

DC 20024. Email: tickbornedisease@

hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Registration information can be found 

on the meeting website at https://

www.hhs.gov/ash/advisory-committees/ 

tickbornedisease/meetings/2021-08-26/ 

index.html when it becomes available. 

The public will have an opportunity to 

present their views to the TBDWG orally 

during the meeting’s public comment 

session or by submitting a written 

public comment. Comments should be 

pertinent to the meeting discussion. 

Persons who wish to provide verbal or 

written public comment should review 

instructions at https://www.hhs.gov/ 

ash/advisory-committees/ 

tickbornedisease/meetings/2021-08-26/ 

index.html and respond by midnight 

August 17, 2021 ET. Verbal comments 

will be limited to three minutes each to 

accommodate as many speakers as 

possible during the 30 minute session. 

Written public comments will be 

accessible to the public on the TBDWG 

web page prior to the meeting. 

Background and Authority: The TickBorne Disease Working Group was 

established on August 10, 2017, in 

accordance with Section 2062 of the 

21st Century Cures Act, and the Federal 

Advisory Committee Act, 5 U.S.C. App., 

as amended, to provide expertise and 

review federal efforts related to all tickborne diseases, to help ensure 

interagency coordination and minimize 

overlap, and to examine research 

priorities. The TBDWG is required to 

submit a report to the HHS Secretary 

and Congress on their findings and any 

recommendations for the federal 

response to tick-borne disease every two 

years. 

Dated: July 9, 2021. 

James J. Berger, 

Designated Federal Officer, Tick-Borne 

Disease Working Group, Office of Infectious 

Disease and HIV/AIDS Policy. 

[FR Doc. 2021–15830 Filed 7–23–21; 8:45 am] 

BILLING CODE 4150–28–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Best Practices for Advancing Cultural 

Competency, Language Access and 

Sensitivity toward Asian Americans 

and Pacific Islanders 

Correction 

In notice document 2021–15168, 

appearing on pages 37757–37758 in the 

issue of Friday, July 16, 2021, make the 

following correction: 

On page 37757, in the third column, 

on the thirty-sixth line from the top, 

‘‘minorityhealth@hhs.gov’’ should read 

‘‘minorityhealth@hhs.gov.’’ 

[FR Doc. C1–2021–15168 Filed 7–23–21; 8:45 am] 

BILLING CODE 0099–10–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of The Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Advisory Committee on 

Research on Women’s Health. 

The meeting will be held as a virtual 

meeting and open to the public. 

Individuals who plan to view the virtual 

meeting and need special assistance or 

other reasonable accommodations to 

view the meeting, should notify the 

Contact Person listed below in advance 

of the meeting. The meeting will be 

videocast and can be accessed from the 

NIH Videocasting and Podcasting 

website (http://videocast.nih.gov/). 

Name of Committee: Advisory Committee 

on Research on Women’s Health. 

Date: September 1, 2021. 

Time: 1:30 p.m. to 2:30 p.m. 

Agenda: Presentation from the ACRWH 

Working Group on the Women’s Health 

Consensus Conference. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Samia Noursi, Ph.D., 

Associate Director, Science Policy, Planning, 

and Analysis, Office of Research on Women’s 

Health, National Institutes of Health, 6707 

Democracy Blvd., Room 402, Bethesda, MD 

20892, 301–496–9472, samia.noursi@nih.gov. 

Name of Committee: Advisory Committee 

on Research on Women’s Health. 

Date: October 20, 2021. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: Reports on Congressionally 

Recommended Women’s Health Priorities: 

Rising Maternal Morbidity and Mortality 

Rates; Rising Rates of Chronic Debilitating 

Conditions in Women; and Stagnant Cervical 

Cancer Survival Rates. 

Date: October 21, 2021. 

Time: 9:30 a.m. to 4:30 p.m. 

Agenda: Director’s Report, NCI Director 

Presentation, Women’s Health Consensus 

Conference Working Group Report, and 

concept clearances for various ORWH 

programs. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Samia Noursi, Ph.D., 

Associate Director, Science Policy, Planning, 

and Analysis, Office of Research on Women’s 

Health, National Institutes of Health, 6707 

Democracy Blvd., Room 402, Bethesda, MD 

20892, 301–496–9472, samia.noursi@nih.gov. 

Any member of the public interested in 

presenting oral comments to the committee 

may notify the Contact Person listed on this 

notice at least 10 days in advance of the 

meetings. Interested individuals and 

representatives of organizations may submit 

a letter of intent, a brief description of the 

organization represented, and a short 

description of the oral presentation. Only one 

representative of an organization may be 

allowed to present oral comments and if 

accepted by the committee, presentations 

may be limited to five minutes. Both printed 

and electronic copies are requested for the 

record. In addition, any interested person 

may file written comments with the 

committee by forwarding their statement to 

the Contact Person listed on this notice. The 

statement should include the name, address, 

telephone number and when applicable, the 

business or professional affiliation of the 

interested person. 

Information is also available on the 

Institute’s/Center’s home page: https://

orwh.od.nih.gov/, where an agenda and any 

additional information for the meeting will 

be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: July 21, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–15865 Filed 7–23–21; 8:45 am] 

BILLING CODE 4140–01–P 


jbell on DSKJLSW7X2PROD with NOTICES